Principal Financial Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-173,080
| Closed | -$14.7M | – | 2495 |
|
|
2020
Q3 | $14.7M | Sell |
173,080
-66,288
| -28% | -$3.35M | 0.01% | 839 |
|
|
2020
Q2 | $8.48M | Buy |
239,368
+186,115
| +349% | +$5.44M | 0.01% | 1152 |
|
|
2020
Q1 | $718K | Buy |
53,253
+2,937
| +6% | +$49.4K | ﹤0.01% | 1797 |
|
|
2019
Q4 | $1.06M | Sell |
50,316
-5,117
| -9% | -$90.3K | ﹤0.01% | 1824 |
|
|
2019
Q3 | $736K | Buy |
55,433
+5,091
| +10% | +$74.8K | ﹤0.01% | 1872 |
|
|
2019
Q2 | $698K | Buy |
50,342
+2,672
| +6% | +$40.2K | ﹤0.01% | 1895 |
|
|
2019
Q1 | $916K | Buy |
47,670
+1,816
| +4% | +$29.3K | ﹤0.01% | 1840 |
|
|
2018
Q4 | $654K | Sell |
45,854
-40,705
| -47% | -$808K | ﹤0.01% | 1870 |
|
|
2018
Q3 | $1.8M | Buy |
86,559
+42,633
| +97% | +$1.01M | ﹤0.01% | 1772 |
|
|
2018
Q2 | $1.04M | Buy |
43,926
+9,932
| +29% | +$200K | ﹤0.01% | 1840 |
|
|
2018
Q1 | $496K | Buy |
33,994
+1,265
| +4% | +$20.7K | ﹤0.01% | 1942 |
|
|
2017
Q4 | $529K | Buy |
32,729
+18,351
| +128% | +$217K | ﹤0.01% | 1946 |
|
|
2017
Q3 | $201K | Sell |
14,378
-2,736
| -16% | -$27.3K | ﹤0.01% | 2110 |
|
|
2017
Q2 | $151K | Sell |
17,114
-564
| -3% | -$3.96K | ﹤0.01% | 2156 |
|
|
2017
Q1 | $114K | Hold |
17,678
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q4 | $65K | Buy |
17,678
+2,052
| +13% | +$6.07K | ﹤0.01% | 2183 |
|
|
2016
Q3 | $51K | Hold |
15,626
| – | – | ﹤0.01% | 2139 |
|
|
2016
Q2 | $36K | Sell |
15,626
-1,215
| -7% | -$4.06K | ﹤0.01% | 2145 |
|
|
2016
Q1 | $42K | Buy |
16,841
+497
| +3% | +$1.12K | ﹤0.01% | 2131 |
|
|
2015
Q4 | $50K | Sell |
16,344
-655
| -4% | -$1.83K | ﹤0.01% | 2148 |
|
|
2015
Q3 | $29K | Sell |
16,999
-9,465
| -36% | -$24.2K | ﹤0.01% | 2168 |
|
|
2015
Q2 | $107K | Buy |
26,464
+3,929
| +17% | +$16.1K | ﹤0.01% | 2124 |
|
|
2015
Q1 | $86K | Buy |
+22,535
| New | +$98K | ﹤0.01% | 2116 |
|
Principal Financial Group's IMMU Position: Q4 2020 in Review
Principal Financial Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 173,080 shares — an estimated $14.7M sold.
Principal Financial Group first reported a position in IMMU in Q1 2015 and held it in 23 quarters. The position peaked at $14.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Principal Financial Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Principal Financial Group sold 173,080 Immunomedics Inc shares in Q4 2020, an estimated $14.7M.
- Principal Financial Group first reported a position in Immunomedics Inc in Q1 2015 and held it in 23 quarters.
- Principal Financial Group's Immunomedics Inc position peaked at $14.7M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.